Insights into Monkeypox - The role of IL-10 signaling and epigenetics in viral persistence

Medical News: In a past study conducted by researchers from the University of Sharjah-UAE and Istinye University-Turkey, new light has been shed on the complex interplay between the monkeypox virus and the human immune system. The study explores how the virus may leverage the interleukin-10 (IL-10) signaling pathway and epigenetic mechanisms to ensure its long-term survival in the host.


 Insights into Monkeypox - The role of IL-10 signaling and epigenetics in viral persistence

This Medical News report delves into the significant findings of this research and their potential implications for public health, especially as the world grapples with yet another viral threat in the wake of the COVID-19 pandemic. The researchers' institutions, played a pivotal role in conducting this study, which could pave the way for new therapeutic approaches to combat monkeypox and similar viral infections.
 
The Growing Threat of Monkeypox
As the world continues to recover from the COVID-19 pandemic, another viral threat has emerged, causing alarm across the globe. Monkeypox, a zoonotic disease primarily transmitted from animals to humans, has seen a resurgence in non-endemic countries, with over 1,300 cases of the Clade 2B strain reported across 50 countries as of mid-2022. While the disease is generally self-limiting and has a low fatality rate, the global spread of the monkeypox virus is a cause for concern. The virus belongs to the same family as the smallpox virus, which historically claimed millions of lives, making it a serious pathogen with the potential for widespread impact.
 
The primary symptoms of monkeypox include fever, headache, muscle aches, fatigue, and characteristic lesions on the skin. Transmission occurs through close contact with infected individuals, bodily fluids, respiratory droplets, and contaminated surfaces. Although no specific treatments for monkeypox are currently available, the disease is mainly managed through supportive care. However, the ability of the monkeypox virus to persist in the upper respiratory tract, even after symptoms have subsided, poses challenges for controlling its spread and highlights the need for further research into effective antiviral therapies.
 
Uncovering the Role of IL-10 Signaling in Viral Persistence
In this study, the researchers employed in silico analysis to investigate how monkeypox virus infection affects gene expression in human host cells. Utilizing publicly available transcriptomic datasets from the National Center for Biotechnology Information Gene Expression Omnibus, the team focused on the GSE36854 dataset, which included expression profiles from HeLa cells either mock-infected or infected with the monkeypox virus strain MSF#6.
 
The study revealed that the monkeypox virus infection leads to the differential expression of 113 genes, with 78 genes being upregulated and 35 downregulated. Among the upregulated genes, a significant number were associated with the IL-10 signaling pathway, a crucial component of the immune system that plays a role in regulating inflammation an d preventing tissue damage during acute immune responses. The study highlights that while IL-10 is essential for maintaining immune homeostasis, viruses can exploit this pathway to evade the immune system, thereby prolonging their survival within the host.
 
The IL-10 signaling pathway, known for its anti-inflammatory properties, is activated by various immune cells, including macrophages, which can facilitate viral spread by carrying the virus to different tissues. The study's findings suggest that the monkeypox virus may be using this pathway to create a more favorable environment for its replication and persistence, raising important questions about how this mechanism could be targeted for therapeutic intervention.
 
The Potential Role of Epigenetics in Monkeypox Viral Persistence
One of the most intriguing aspects of the study is the suggestion that epigenetic mechanisms may play a role in the long-term persistence of the monkeypox virus. Epigenetics refers to changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes can be triggered by various factors, including environmental influences, infections, and immune responses.
 
The study found that many of the IL-10 signaling genes identified in the research possess CpG island-rich promoter regions, making them highly susceptible to epigenetic regulation. This observation raises the possibility that the monkeypox virus could be using epigenetic modifications to manipulate the host's immune response, allowing the virus to persist within the host for extended periods.
 
Previous research has shown that other viruses, such as hepatitis and SARS-CoV-2, can induce epigenetic changes that promote viral survival and replication. For instance, DNA methylation, a common epigenetic modification, has been linked to the regulation of immune responses during viral infections. In the case of monkeypox, the researchers hypothesize that similar mechanisms could be at play, with the virus potentially using DNA methylation to upregulate IL-10 signaling genes and suppress the host's immune response.
 
Implications for Future Research and Public Health
The findings of this study have significant implications for our understanding of monkeypox and other viral infections. By identifying the IL-10 signaling pathway and epigenetic regulation as potential factors in the long-term persistence of the monkeypox virus, the researchers have opened new avenues for therapeutic research. Targeting these mechanisms could lead to the development of novel antiviral therapies that not only treat the symptoms of monkeypox but also prevent the virus from establishing a persistent infection.
 
Moreover, the study underscores the importance of further research into the epigenetic regulation of immune responses during viral infections. As our understanding of these complex interactions grows, so too does the potential for new treatments that could help to control or even eradicate persistent viral infections like monkeypox.
 
Conclusion
The study findings provide valuable insights into the mechanisms by which the monkeypox virus may persist within the host. By upregulating the IL-10 signaling pathway and potentially exploiting epigenetic modifications, the virus appears to create an environment conducive to its long-term survival. These findings not only enhance our understanding of monkeypox but also highlight the broader significance of epigenetics in viral persistence.
 
As the world faces the ongoing threat of monkeypox, this research offers a glimmer of hope for the development of new therapeutic strategies. By targeting the IL-10 signaling pathway and epigenetic mechanisms, future treatments could potentially prevent the virus from establishing a persistent infection, thereby reducing its impact on public health.
 
The study findings were published in the peer-reviewed journal: Hospital Practice.
https://www.tandfonline.com/doi/full/10.1080/21548331.2023.2179770
 
For the latest Mpox news, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/israeli-researchers-identify-viroporins-in-mpox-virus-that-can-be-exploited-for-treatments
 
https://www.thailandmedical.news/news/mpox-evades-the-human-immune-system-by-having-its-viral-protein-m2-bind-to-host-b7-1-and-b7-2-proteins